Immix Biopharma (IMMX) Stock
Immix Biopharma (IMMX) closed at $7.48 on Nov 16, 2026; its Tenet Score is 69 of 100 against 409 Healthcare peers.
Key stats
- Previous close
- $7.48
- Nov 16, 2026
- Market cap
- $626.9M
- share price × the latest quarter's diluted weighted-average share count (vendor)
- Dividend yield
- 0.00%
- reinvests all
- 52-week range
- 3.45 – 15.10
- low → high
- Tenet Score
- 69/100
- Solid · 409 Healthcare peers
Industry: Drugs · see every company filed here →
Immix Biopharma Inc scores 69/100. Solid. Strongest on financial health and value, quality is the soft spot versus 409 Healthcare peers. Insufficient inputs: Tenet 69 is built from 3 of 4 pillars, from 35% of its inputs. The pillars showing a dash had no data.
Tenet Score · vs sector
n=409Factor grades
Growth omitted — no data yet.
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Drawdown Context
- ✕ Reversal Evidence
- ✓ Not-a-Value-Trap Gate
Pays no dividend. Every dollar of profit is reinvested into the business.
13F flows & insider trades land here.
Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 13, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Janux Therapeutics IncJANX | 74 | $695.7M |
| DBV TechnologiesDBVT | 32 | $692.6M |
| Universe Pharmaceuticals INCUPC | 64 | $688.4M |
| Cullinan Therapeutics IncCGEM | 54 | $667.4M |
| Olema Oncology Inc.OLMA | 55 | $662.3M |
| Arbutus Biopharma CorpABUS | 49 | $627.0M |
| Geron Corp.GERN | 56 | $623.0M |
| Wave Life Sciences Inc.WVE | 54 | $617.3M |
| Pacific Biosciences of California, IncPACB | 40 | $613.3M |
| Climb Bio Inc.CLYM | 62 | $608.5M |
Common questions
What sector and industry is Immix Biopharma in?
Immix Biopharma is in the Healthcare sector and the Drugs industry.
What is Immix Biopharma's Tenet Score?
Immix Biopharma's Tenet Score is 69 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.




